Search
Haloprogesterone
go.drugbank.com/drugs/DB20259ExperimentalHaloprogesterone has a monoisotopic molecular weight of 410.13 Da. … Haloprogesterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Haloprogesterone is a antiandrogen.
Tallimustine
go.drugbank.com/drugs/DB15466ExperimentalTallimustine, a benzoyl mustard derivative of distamycin A, is an alkylating agent that binds to the minor groove of DNA. … [A182039,A182045] Newer generations of DNA minor groove binding agents can more specifically recognize base pair sequences.[A182051]
Oxilofrine
go.drugbank.com/drugs/DB11610ApprovedOxilofrine is used in combination with DB11609 as an antitussive. It is currently marketed in Canada by Valeant under the tradename Cophylac.
Vusolimogene oderparepvec
go.drugbank.com/drugs/DB23008ApprovedInvestigationalon a PD-1-blocking antibody-based regimen. … Vusolimogene oderparepvec-wtpg is a genetically modified herpes simplex virus type 1 (HSV-1) oncolytic viral therapy used, in combination with [nivolumab], to treat advanced melanoma.
Categories: DNA VirusesFerric carboxymaltose
go.drugbank.com/drugs/DB08917ApprovedInvestigationalIt was FDA approved on July 25, 2013.
Categories: Compounds used in a research, industrial, or household settingIodocetylic acid I-123
go.drugbank.com/drugs/DB19593ExperimentalIodocetylic acid I-123 is a small molecule drug. Iodocetylic acid I-123 has a monoisotopic molecular weight of 378.14 Da.
Thioproperazine
go.drugbank.com/drugs/DB01622ApprovedThioproperazine is a potent neuroleptic with antipsychotic properties. … Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects.
Categories: Dopamine D2 Receptor AntagonistsShark liver oil
go.drugbank.com/drugs/DB11088ApprovedShark oil is a rich source of alkylglycerols and squalene, with relatively low amounts of n-3 polyunsaturated fatty acids.
Mixtures: DG Health HemorrhoidalBetrixaban
go.drugbank.com/drugs/DB12364ApprovedBetrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [A7708]. … It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [A27286].
Categories: Factor Xa Inhibitors, Direct factor Xa inhibitors